Additional Information
Short Description: |
Proteasome inhibitor |
Research Area: |
Cell Signaling |
Alternative Name(s): |
N-Acetyl-N-methyl-L-isoleucyl-L-isoleucyl-N-[(1S)-3-methyl-1-[[(2R)-2-methyloxiranyl]carbonyl]butyl]-L-threoninamide |
Category: |
Small Molecules |
Product Type: |
Inhibitor |
CAS No.: |
134381-21-8 |
Molecular Formula: |
C28H50N4O7 |
Molecular Weight: |
554,7 |
Source: |
Synthetic |
Purity: |
>95% |
Solubility: |
Soluble in DMSO (15 mg/ml) or dichloromethane:methanol (9:1); insoluble in water. |
Appearance: |
White solid |
Storage: |
-20ºC |
Shipping: |
Shipped Ambient |
SMILES: |
[C@@H](CC)(C)[C@@H](C(N[C@H](C(N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(=O)NCC(=O)[C@]1(C)OC1)CC(C)C)=O)[C@H](CC)C)=O)N(C)C |
InChI: |
InChI=1S/C28H50N4O7/c1-11-16(5)21(30-27(38)23(17(6)12-2)32(10)19(8)34)25(36)31-22(18(7)33)26(37)29-20(13-15(3)4)24(35)28(9)14-39-28/h15-18,20-23,33H,11-14H2,1-10H3,(H,29,37)(H,30,38)(H,31,36)/t16-,17-,18+,20-,21-,22-,23-,28+/m0/s1 |
InChIKey: |
DOGIDQKFVLKmlQ-JTHVHQAWSA-N |
Field of Use: |
For in vitro research use only. |
Related Products
Epoxomicin | A2606
607
NULL240.00 - NULL607.00
Epoxomicin | A2606 | Gentaur UK, US & Europe Distribution
607-A2606
Epoxomicin | 2190
26
NULL339.00 - NULL863.00
Originally isolated from Actinomycetes strain based on its potent in vivo antitumor activity, Epoxomicin is a potent, cell-permeable, selective and irreversible proteasome inhibitor. More potent...
26-2190-GEN
